BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 34158353)

  • 1. Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study.
    Stouten V; Pazmino S; Verschueren P; Mamouris P; Westhovens R; de Vlam K; Bertrand D; Van der Elst K; Vaes B; De Cock D
    RMD Open; 2021 Jun; 7(2):. PubMed ID: 34158353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis.
    Lauper K; Courvoisier DS; Chevallier P; Finckh A; Gabay C
    Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1756-1763. PubMed ID: 29609199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.
    Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G
    Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.
    Michelsen B; Fiane R; Diamantopoulos AP; Soldal DM; Hansen IJ; Sokka T; Kavanaugh A; Haugeberg G
    PLoS One; 2015; 10(4):e0123582. PubMed ID: 25853482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.
    Pombo-Suarez M; Sanchez-Piedra C; Garcia-Magallón B; Pérez-Gómez A; Manrique-Arija S; Martín-Doménech R; Colazo M; Campos C; Campos J; Del Pino-Montes J; Arteaga MJ; Cea-Calvo L; Díaz-González F; Gómez-Reino JJ
    Clin Rheumatol; 2021 Oct; 40(10):3979-3988. PubMed ID: 33907904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-traumatic stress disorder prior to diagnosis is as rare in spondyloarthritis as in non-inflammatory rheumatic conditions and rheumatoid arthritis.
    Fan A; Glace B; Pereira B; Malochet-Guinamand S; Couderc M; Mathieu S; Tournadre A; Soubrier M; Dubost JJ
    Joint Bone Spine; 2023 Mar; 90(2):105500. PubMed ID: 36574573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Certolizumab-Pegol in Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis Based on the BIOPURE Registry: Can Early Response Predict Late Outcomes?
    Iannone F; Semeraro A; Carlino G; Santo L; Bucci R; Quarta L; Maruotti N; Zuccaro C; Marsico A; Falappone PCF; Mazzotta D; Cantatore FP; Muratore M; Lapadula G
    Clin Drug Investig; 2019 Jun; 39(6):565-575. PubMed ID: 30941736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity in psoriatic arthritis and rheumatoid arthritis.
    Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
    Intern Med J; 2018 Nov; 48(11):1360-1368. PubMed ID: 30047189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study.
    Grellmann C; Dombrowsky W; Fabricius V; Suruki R; Sheahan A; Joeres L
    Adv Ther; 2021 Jan; 38(1):366-385. PubMed ID: 33128201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.
    Sheahan A; Anjohrin S; Suruki R; Stark JL; Sloan VS
    Clin Rheumatol; 2024 Jun; 43(6):1897-1907. PubMed ID: 38658403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?
    Hasseli R; Pfeil A; Hoyer BF; Krause A; Lorenz HM; Richter JG; Schmeiser T; Voll RE; Schulze-Koops H; Specker C; Müller-Ladner U
    Clin Exp Rheumatol; 2021; 39(3):639-647. PubMed ID: 33822706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-year follow-up of inflammatory arthropathy patients treated with golimumab: Data from the observational multicentre NOR-DMARD study.
    Michelsen B; Sexton J; Wierød A; Bakland G; Rødevand E; Krøll F; Kvien TK
    Semin Arthritis Rheum; 2020 Feb; 50(1):12-16. PubMed ID: 31358361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway.
    Kerola AM; Sexton J; Wibetoe G; Rollefstad S; Crowson CS; Mars N; Kazemi A; Haavardsholm EA; Kvien TK; Semb AG
    Semin Arthritis Rheum; 2021 Oct; 51(5):1081-1088. PubMed ID: 34450506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.
    Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
    Arthritis Res Ther; 2017 May; 19(1):102. PubMed ID: 28521824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of classification criteria for peripheral spondyloarthritis and psoriatic arthritis in the Leiden Early Arthritis cohort.
    van den Berg R; van Gaalen F; van der Helm-van Mil A; Huizinga T; van der Heijde D
    Ann Rheum Dis; 2012 Aug; 71(8):1366-9. PubMed ID: 22504563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriatic arthritis and spondyloarthritis assessment and management update.
    Mease P
    Curr Opin Rheumatol; 2013 May; 25(3):287-96. PubMed ID: 23492739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Ramiro S; Radner H; van der Heijde D; van Tubergen A; Buchbinder R; Aletaha D; Landewé RB
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008886. PubMed ID: 21975788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis.
    Pombo-Suárez M; Seoane-Mato D; Díaz-González F; Cea-Calvo L; Sánchez-Alonso F; Sánchez-Jareño M; Jovani V; García-Magallón B; Martínez-González O; Campos-Fernández C; Manero J; Díaz-Torne C; Bohórquez C; Ros-Vilamajó I; Pérez-Vera Y; Castrejón I
    Musculoskeletal Care; 2023 Mar; 21(1):189-197. PubMed ID: 35996810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis.
    Jarlborg M; Courvoisier DS; Lamacchia C; Martinez Prat L; Mahler M; Bentow C; Finckh A; Gabay C; Nissen MJ;
    Arthritis Res Ther; 2020 May; 22(1):105. PubMed ID: 32375861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study.
    Fong W; Woon TH; Chew LC; Low A; Law A; Poh YJ; Yeo SI; Leung YY; Ma M; Santosa A; Kong KO; Xu C; Teng GG; Mak A; Tay SH; Chuah TY; Roslan NE; Angkodjojo S; Phang KF; Sriranganathan M; Tan TC; Cheung P; Lahiri M
    Adv Rheumatol; 2023 Aug; 63(1):38. PubMed ID: 37528453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.